Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ARES vs GSK✓SelectedUSD · GSKARES vs GSK performance historyLatest closeAs of+0.99%11/13
Stock and ETF performance explorer

ARES vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,101.7%
GSK return
+105.0%
Excess return
+996.7%
Maximum drawdown
-50.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%+0.5%+0.5%+0.8%
7D+0.5%+1.1%-0.7%+0.1%
30D+19.7%+6.3%+13.3%+17.3%
3M-9.0%+1.8%-10.8%-9.6%
6M+11.5%+1.7%+9.9%+10.5%
YTD-13.8%+6.5%-20.4%-16.8%
1Y-5.6%+9.5%-15.1%-9.9%
3Y+36.1%+65.3%-29.2%+4.4%
5Y+82.7%+43.7%+38.9%+47.9%
All+1,101.7%+105.0%+996.7%+744.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling